1-4 of 4
Kristen Detweiler Short, RN, CNP
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Increased Incidence of Extramedullary Plasmacytomas In Patients with Multiple Myeloma In the Era of Novel Therapy and Effect of Pomalidomide on Extramedullary Disease

Kristen Detweiler Short, RN, CNP, S. Vincent Rajkumar, MD, Francis Buadi, MD, Dirk Larson, Suzanne R. Hayman, MD, Angela Dispenzieri, MD, Morie Abraham A Gertz, MD, Shaji Kumar, MD, Joseph R. Mikhael, MD, Vivek Roy, Robert Kyle, MD, Martha Lacy, MD
Journal: Blood
Blood (2010) 116 (21): 3047.
https://doi.org/10.1182/blood.V116.21.3047.3047
Published: 2010
Journal Articles

Response to Salvage Therapies and Outcome of Patients with Multiple Myeloma Relapsing After Pomalidomide Therapy

Shirshendu Sinha, MBBS, Shaji Kumar, MD, Suzanne Hayman, MD, Francis Buadi, MD, Kristen Detweiler Short, RN, CNP, Joseph Mikhael, MD, Angela Dispenzieri, MD, Morie Gertz, MD, David Dingli, M.D., Ph.D., S. Vincent Rajkumar, MD, Martha Lacy, MD
Journal: Blood
Blood (2010) 116 (21): 1965.
https://doi.org/10.1182/blood.V116.21.1965.1965
Published: 2010
Journal Articles

Pomalidomide Plus Low-Dose Dexamethasone In Myeloma Refractory to Both Bortezomib and Lenalidomide: Comparison of Two Dosing Strategies In Dual-Refractory Disease

Martha Lacy, MD, Sumithra Mandrekar, PhD, Morie Abraham A Gertz, MD, Suzanne R. Hayman, MD, Kristen Detweiler Short, RN, CNP, Francis Buadi, MD, Angela Dispenzieri, M.D., Shaji Kumar, MD, Steven Zeldenrust, MD, PhD, David Dingli, M.D., Ph.D., Philip R. Greipp, MD, John Lust, MD, PhD, Stephen Russell, MD, PhD, Robert Kyle, MD, Rafael Fonseca, MD, P. Leif Bergsagel, MD, Vivek Roy, MD, A. Keith Stewart, MD, Jacob Allred, Kristina Laumann, Craig B. Reeder, MD, S. Vincent Rajkumar, MD, Joseph R. Mikhael, MD
Journal: Blood
Blood (2010) 116 (21): 863.
https://doi.org/10.1182/blood.V116.21.863.863
Published: 2010
Journal Articles

Pomalidomide (CC4047) Plus Low Dose Dexamethasone (Pom/dex) Is Active and Well Tolerated in Lenalidomide Refractory Multiple Myeloma (MM).

Martha Q. Lacy, MD, Morie A Gertz, MD, Suzanne R. Hayman, MD, Kristen Detweiler Short, RN, CNP, Angela Dispenzieri, MD, Shaji Kumar, MD, Steven R. Zeldenrust, M.D., Ph.D., Philip R. Greipp, MD, John A. Lust, MD, PhD, Stephen J. Russell, MD, PhD, Francis Buadi, MD, Robert Kyle, MD, Rafael Fonseca, MD, P. Leif Bergsagel, MD, Vivek Roy, MD, FACP, Joseph R. Mikhael, MD, A. Keith Stewart, MD, Craig B. Reeder, MD, David Dingli, MD, PhD, Jacob Allred, Kristina Laumann, Sumithra Mandrekar, PhD, S. Vincent Rajkumar, MD
Journal: Blood
Blood (2009) 114 (22): 429.
https://doi.org/10.1182/blood.V114.22.429.429
Published: 2009